ARCHIVES

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Halterman, Mahoney And Their Grants Go To DCT, Along With Some Program Projects

March 17, 1978

NCI To End CIS Partnership Program In 2010.

December 5, 2008

In Brief: Carcinogenesis: Does The Promise Justify The Effort? Task Force Attempts To Find Out

September 30, 1977

DCBD Concepts Approved

November 8, 1985

Cancer Congress Scientific Program To Update Basic, Clinical Science

April 2, 1982

AVEO’s Tizozanib Fails in Colorectal Cancer

January 10, 2014